A Phase 1 Study to Evaluate the Immunogenicity and Safety of a Pandemic Avian Influenza Vaccine in Adults

Condition:   InfluenzaInterventions:   Biological: recombinant influenza hemagglutinin;   Biological: Advax1;   Biological: Advax2Sponsors:   Vaxine Pty Ltd;   Flinders Medical Centre;   Australian Respiratory and Sleep Medicine InstituteNot yet recruiting - verified January 2015

Source: ClinicalTrials.gov - January 4, 2015 Category: Research Source Type: clinical trials